Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.4K
Overview
85.4K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

3.8K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NLRP6 regulates donor T cell activation and acute graft-<i>versus</i>-host disease via ZAP-70-Erk pathway.

Haematologica·2026
Same author

Tocilizumab: From Bench to Bedside - A Comprehensive Review.

Kansas journal of medicine·2026
Same author

MHC class I on target cells regulates CD4<sup>+</sup> T cell-mediated immunity.

Nature immunology·2026
Same author

Author Correction: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.

Nature immunology·2026
Same author

Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant.

Pediatric blood & cancer·2026
Same author

Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: Mar 8, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K

Tissue tolerance: a distinct concept to control acute GVHD severity.

Shin-Rong Wu1,2, Pavan Reddy2

  • 1Graduate Program in Immunology and.

Blood
|February 4, 2017
PubMed
Summary

Graft-versus-host disease (GVHD) severity can be reduced by focusing on "tissue tolerance" – the inherent ability of tissues to resist damage and repair themselves. This approach offers a new strategy beyond targeting immune cells for managing GVHD.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

10.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

10.3K

Area of Science:

  • Immunology
  • Transplantation Biology
  • Tissue Engineering

Background:

  • Acute graft-versus-host disease (GVHD) is a severe complication of allogeneic stem cell transplantation, primarily attributed to pathological immune responses.
  • Current management strategies for GVHD predominantly focus on modulating immune cells to induce immune tolerance.
  • The contribution of tissue-intrinsic factors to GVHD severity has been largely overlooked.

Purpose of the Study:

  • To introduce and define the concept of "tissue tolerance" in the context of alloimmune diseases.
  • To explore tissue-specific programs that influence resilience, repair, and regeneration in GVHD.
  • To propose "tissue tolerance" as a novel therapeutic avenue for mitigating GVHD severity.

Main Methods:

  • Literature review and conceptual framework development.
  • Analysis of existing data on tissue responses in alloimmune settings.
  • Comparative analysis with plant immune responses to disease.

Main Results:

  • Tissue-intrinsic factors play a significant, yet underappreciated, role in modulating GVHD severity.
  • The concept of "tissue tolerance" encompasses mechanisms of target tissue resilience, repair, and regeneration.
  • Targeting tissue tolerance may mitigate GVHD without compromising necessary immune cell function.

Conclusions:

  • "Tissue tolerance" represents a paradigm shift in understanding and managing GVHD.
  • Harnessing tissue-intrinsic repair and resilience mechanisms offers a promising strategy for GVHD treatment.
  • Future research should focus on identifying and manipulating these tissue-specific programs to improve transplant outcomes.